Cu/Zn-superoxide dismutase, paraoxonase and arylesterase activities and malondialdehyde levels in patients with familial mediterranean fever

Bratislava Medical Journal

Volumn 113, Issue 9, 2012, Pages 561-564

  Yildirim, K ^a   Uzkeser, H ^a   Keles, M ^a   Yildirim, S ^a   Karatay, S ^a   Kiziltunc, A ^a   Ugur, M ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Arylesterase; Cu Zn superoxide dismutase; Familial mediterranean fever; Malondialdehyde; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CARBOXYLESTERASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BLOOD; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; MALE; MIDDLE AGED;

ADULT; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84871804115     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2012_126     Document Type: Article

References (35)

1. Orbach H, Ben-Chetrit E. Familial Mediterranean Fever ? a review and update. Minerva Med 2001; 92 (6): 421 - 430.
2. Karatay S, Yildirim K, Keles M et al. Serum serotonin level and its association with pain in FMF patients. EAJM 2007; 39 (2): 81 - 84.
3. Kuloglu M, Atmaca M, Tezcan E, Ustundag B, Bulut S. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 2002; 46 (4): 186 - 189.
4. Tuzun A, Erdil A, Inal V et al. Oxidative stress and antioxidant capacity in patients with infl ammatory bowel disease. Clinical Biochemistry 2002; 35 (7): 569 - 572.
5. Ji LL, Gomez-Cabrera MC, Vina J. Role of free radicals and antioxidant signaling in skeletal muscle health and pathology. Infect Disord Drug Targets 2009; 9 (4): 428 - 444.
6. Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone infl ammatory diseases: a review of published adduct types and levels in humans. Free Radic Biol Med 2007; 43 (8): 1109 - 1120.
7. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 2007; 74 (4): 324 - 329.
8. Canales A, Sanchez-Muniz FJ. Paraoxanase, something more than an enzyme? Med Clin (Barc) 2003; 121 (14): 537 - 548.
9. Getz GS, Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol 2004; 15 (3): 261 - 267.
10. Blatter MC, James RW, Messmer S, Barja F, Pometta D. Identifi cation of a distinct human high-density lipoprotein subspecies defi ned by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993; 211 (3): 871 - 879.
11. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 1996; 7 (2): 69 - 76.
12. Eckerson HW, Wyte CM, La Du BN. The Human Serum Paraoxonase/ Arylesterase Polymorphism. Am J Hum Genet 1983; 35 (6): 1126 - 1138.
13. Toker A, Kadi M, Yildirim AK, Aksoy H, Akçay F. Serum lipid profi le paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 2009; 27 (3): 176 - 180.
14. Gurbuz M, Yamanel L, Bulucu F, Inal V, Aydin A. Oxidative stress status in familial Mediterranean fever with or without proteinuria. Free Radic Biol Med 2005; 38 (2): 271 - 275.
15. Canakci CF, Cicek Y, Yildirim A, Sezer U, Canakci V. Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur J Dent 2009; 3 (2): 100 - 106.
16. Livneh A, Langevitz P, Zemer D et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40 (10): 1879 - 1885.
17. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34 (3): 497 - 500.
18. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycocylated hemoglobin in diabetes. Diabetes 1989; 38 (12): 1539 - 1543 .
19. Briviba K, Sies H. Nonenzymatic Antioxidant Defense Systems. 107 - 128. In: Frei B. (Ed). Natural Antioxidants in Human Health and Disease. San Diego; Academic Press, 1994.
20. Kali G, Tunca M, Genc S, Jaruga P, Dizdaroglu M. Oxidative DNA damage in polymorphonuclear leukocytes of patients with familial Mediterranean fever. Free Radic Biol Med 2008; 44 (3): 386 - 393.
21. Korkmaz C, Ozdogan H, Kasapcopur O, Yazici H. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61 (1): 79 - 81.
22. Karatay S, Yildirim K, Uyanik A et al. Increased serum concentrations of homocysteine and lipoprotein (a) in familial Mediterranean fever. Ann Clin Lab Sci 2010; 40 (1): 10 - 14.
23. Kiraz S, Ertenli I, Arici M et al. Effects of colchicine on infl ammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 1998; 16 (6): 721 - 724
24. Taysi S, Gul M, Sari RA, Akcay F, Bakan N Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 2002; 40 (7): 684 - 688.
25. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 2004; 24 (2): 80 - 83.
26. Renke J, Szlagatys A, Hansdorfer-Korzon R et al. Persistence of protein oxidation products and plasma antioxidants in juvenile idiopathic arthritis. A one-year follow-up study. Clin Exp Rheumatol 2007; 25 (1): 112 - 114.
27. Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002; 21 (5): 200 - 204.
28. Taysi S, Kocer I, Memisogullari R, Kiziltunc A. Serum oxidant/antioxidant status in patients with Behçet's disease. Ann Clin Lab Sci 2002; 32 (4): 377 - 382.
29. Gan KN, Smolen A, Eckerson HW, La Du BN. Purifi cation of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991; 19 (1): 100 - 106.
30. Mackness B, Durrington PN, Abuashia B, Boulton AJ, Mackness MI. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin Sci 2000; 98 (3): 355 - 363.
31. Bodolay E, Seres I, Szodoray P et al. Evaluation of paraoxonase activity in patients with mixed connective tissue disease. J Rheumatol 2008; 35 (2): 237 - 243.
32. Baskol G, Demir H, Baskol M et al. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 2005; 38 (10): 951 - 955.
33. Gullulu M, Kahvecioglu S, Dirican M et al. Paraoxonase activity in glomerulonephritic patients. Ren Fail 2007; 29 (4): 433 - 439.
34. Tanimoto N, Kumon Y, Suehiro T et al. Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci 2003; 72 (25): 2877 - 2885.
35. Erdem FH, Karatay S, Yildirim K, Kiziltunc A. Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients. Clinics (Sao Paulo) 2010; 65 (2): 175 - 179.